SUSAN SHUMATE: Open Payments
NPI 1649539925 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 47 payments from 15 companies in 2025. Trend: 2023 $793 · 2024 $1,005 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $297 |
| Novo Nordisk Inc | 10 | $177 |
| Lilly USA, LLC | 2 | $140 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Amgen Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: VRAYLAR, KISUNLA, Wegovy, UBRELVY, Auvelity, Ozempic, CAPLYTA, TRINTELLIX.
Industry payments across KY — which companies pay providers there.
